The role of PET/CT in oncogynecology (literature review)-Reference-Cited by-同舟云学术

The role of PET/CT in oncogynecology (literature review)

Published:2023-02-08 Issue:1 Volume:27 Page:145-157
ISSN:2408-9516
Container-title:Medical Visualization
language:
Short-container-title:Medicinskaâ vizualizaciâ

Author:

Nikolaeva E. A.¹^ORCID,Tarachkova E. V.²^ORCID,Sheikh Zh. V.³^ORCID,Tyurin I. E.¹^ORCID

Affiliation:

1. N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Healthcare of the Russian Federation; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation

2. Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation

3. Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation; Federal Medical Biophysical Center named after A.I. Burnazyan; S.P. Botkin City Clinical Hospital

Abstract

Purpose: to consider the modern possibilities of positron emission tomography combined with computed tomography (PET/CT) with FDG in the diagnosis of oncological formations in gynecology.Materials and methods. Search, selection and evaluation of existing foreign and domestic research included in the peer-reviewed E-library, PubMed, GoogleScholar, Scopus.Results. This article summarizes the existing evidence base to establish the clinical relevance and new possibilities for the use of FDG PET/CT in common gynecological malignancies.Conclusion. The use of FDG PET/CT can have a significant impact on patient management by improving cancer staging, influencing patient choice for treatment, and detecting early disease recurrence.

Publisher

Vidar, Ltd.

Subject

Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Reference72 articles.

1. Lerman H., Metser U., Grisaru D. et al. Normal and abnormal 18 F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J. Nucl. Med. 2004; 45 (2): 266–271. PMID: 14960646.1

2. Kim T.H., Kim M.R., Jung Y., An Y.S. Relationship between sex hormones levels and 18 F-FDG uptake by the ovaries in premenopausal woman. Radiol. Oncol. 2019; 53 (3): 293–299. http://doi.org/10.2478/raon-2019-0035

3. Burger I.A., Scheiner D.A., Crook D.W. et al. FDG uptake in vaginal tampons is caused by urinary contamination and related to tampon position. Eur. J. Nucl. Med. Mol. Imaging. 2011; 38 (1): 90–96. http://doi.org/10.1007/s00259-010-1618-7

4. Najmabadi S., Schliep K.C., Simonsen S.E. et al. Menstrual bleeding, cycle length, and follicular and luteal phase lengths in women without known subfertility: A pooled analysis of three cohorts. Paediatr. Perinat. Epidemiol. 2020; 34 (3): 318–327. http://doi.org/10.1111/ppe.12644

5. Nishizawa S., Inubushi M., Okada H. Physiological 18 F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur. J. Nucl. Med. Mol. Imaging. 2005; 32 (5): 549–556. http://doi.org/10.1007/s00259-004-1703-x